Year |
Citation |
Score |
2023 |
Gupta A, Nadaf A, Ahmad S, Hasan N, Imran M, Sahebkar A, Jain GK, Kesharwani P, Ahmad FJ. Dasatinib: a potential tyrosine kinase inhibitor to fight against multiple cancer malignancies. Medical Oncology (Northwood, London, England). 40: 173. PMID 37165283 DOI: 10.1007/s12032-023-02018-5 |
0.301 |
|
2022 |
Walker RR, Patel JR, Gupta A, Davidson AM, Williams CC, Payton-Stewart F, Boué SM, Burow ME, Khupse R, Tilghman SL. Glyceollins Trigger Anti-Proliferative Effects in Hormone-Dependent Aromatase-Inhibitor-Resistant Breast Cancer Cells through the Induction of Apoptosis. International Journal of Molecular Sciences. 23. PMID 35270029 DOI: 10.3390/ijms23052887 |
0.501 |
|
2020 |
Gupta A, Gupta G, Mehta RR, Ivancic DZ, Walker RR, Patel JR, Gallegos KM, Davidson AM, Khan SA, Mehta RG, Tilghman SL. A novel and cost-effective ex vivo orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. Biology Open. PMID 34004720 DOI: 10.1242/bio.051649 |
0.694 |
|
2020 |
Gupta A, Gupta G, Mehta RR, Ivancic DZ, Walker RR, Patel JR, Gallegos KM, Davidson AM, Khan SA, Mehta RG, Tilghman SL. A novel and cost-effective orthotopic model for the study of human breast cancer in mouse mammary gland organ culture. Biology Open. PMID 32366373 DOI: 10.1242/Bio.051649 |
0.696 |
|
2016 |
Alimirah F, Peng X, Gupta A, Yuan L, Welsh J, Cleary M, Mehta RG. Crosstalk between the vitamin D receptor (VDR) and miR-214 in regulating SuFu, a hedgehog pathway inhibitor in breast cancer cells. Experimental Cell Research. PMID 27693451 DOI: 10.1016/J.Yexcr.2016.08.012 |
0.704 |
|
2016 |
Clare SE, Gupta A, Choi M, Ranjan M, Lee O, Wang J, Ivancic DZ, Kim JJ, Khan SA. Progesterone receptor blockade in human breast cancer cells decreases cell cycle progression through G2/M by repressing G2/M genes. Bmc Cancer. 16: 326. PMID 27215412 DOI: 10.1186/S12885-016-2355-5 |
0.503 |
|
2016 |
Mehta R, Montembault M, Warren F, Gupta A, Brealey N, Moore A. Systemic Exposures of Fluticasone Propionate and Salmeterol Following Inhalation via Metered Dose Inhaler with the Mini Spacer Compared with the Aerochamber Plus Spacer. Journal of Aerosol Medicine and Pulmonary Drug Delivery. PMID 26824933 DOI: 10.1089/jamp.2015.1236 |
0.447 |
|
2015 |
Brealey N, Gupta A, Renaux J, Mehta R, Allen A, Henderson A. Pharmacokinetics of fluticasone furoate, umeclidinium, and vilanterol as a triple therapy in healthy volunteers. International Journal of Clinical Pharmacology and Therapeutics. PMID 26227101 DOI: 10.5414/CP202390 |
0.456 |
|
2015 |
Mehta R, Riddell K, Gupta A, Louey MD, Chan RH. Comparison of the Pharmacokinetics of Salmeterol and Fluticasone Propionate 50/100 µg Delivered in Combination as a Dry Powder Via a Capsule-Based Inhaler and a Multi-Dose Inhaler. Clinical Drug Investigation. 35: 319-26. PMID 25805608 DOI: 10.1007/s40261-015-0282-x |
0.445 |
|
2014 |
Hu H, Wang J, Gupta A, Shidfar A, Branstetter D, Lee O, Ivancic D, Sullivan M, Chatterton RT, Dougall WC, Khan SA. RANKL expression in normal and malignant breast tissue responds to progesterone and is up-regulated during the luteal phase. Breast Cancer Research and Treatment. 146: 515-23. PMID 25007964 DOI: 10.1007/S10549-014-3049-9 |
0.507 |
|
2013 |
Wang J, Gupta A, Hu H, Chatterton RT, Clevenger CV, Khan SA. Comment on "Progesterone/RANKL is a major regulatory axis in the human breast". Science Translational Medicine. 5: 215le4. PMID 24337478 DOI: 10.1126/Scitranslmed.3006883 |
0.418 |
|
2013 |
Mehta RR, Katta H, Kalra A, Patel R, Gupta A, Alimirah F, Murillo G, Peng X, Unni A, Muzzio M, Mehta RG. Efficacy and mechanism of action of Deguelin in suppressing metastasis of 4T1 cells. Clinical & Experimental Metastasis. 30: 855-66. PMID 23645347 DOI: 10.1007/S10585-013-9585-6 |
0.743 |
|
2013 |
Gupta A, Mehta R, Alimirah F, Peng X, Murillo G, Wiehle R, Mehta RG. Efficacy and mechanism of action of Proellex, an antiprogestin in aromatase overexpressing and Letrozole resistant T47D breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology. 133: 30-42. PMID 22939887 DOI: 10.1016/J.Jsbmb.2012.08.004 |
0.762 |
|
2013 |
Gupta A, Ivancic D, Wang J, Horvath E, Lee O, Whiele R, Khan S. Abstract P2-09-10: Antiprogestin CDB4124 suppressed progesterone receptor-mediated DNA binding activity, proliferation and gene expression in T47D cancer cells and normal human breast microstructures Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-09-10 |
0.515 |
|
2012 |
Kalra AP, Gupta A, Patel R, Katta H, Hawthorne M, Murillo G, Mehta R, Mehta R. Abstract 3829: Inhibition of breast cancer metastasis by deguelin in an experimental model Cancer Research. 72: 3829-3829. DOI: 10.1158/1538-7445.Am2012-3829 |
0.702 |
|
2012 |
Mehta R, Alimirah F, Gupta A, Kalra A, Mehta R. Abstract 3812: Deguelin as a novel therapeutic agent for Herceptin resistant breast cancers Cancer Research. 72: 3812-3812. DOI: 10.1158/1538-7445.Am2012-3812 |
0.758 |
|
2012 |
Gupta A, Mehta RR, Wiehle R, Hawthorne M, Mehta RG. Abstract 3275: Development of a newex-vivoorthotopic model-Human breast cancer cells in mouse mammary gland organ culture Cancer Research. 72: 3275-3275. DOI: 10.1158/1538-7445.Am2012-3275 |
0.705 |
|
2011 |
Gupta A, Mehta R, Alimirah F, Murillo G, Peng X, Wiehle R. P2-17-05: Antiprogestin Proellex Suppresses Proliferation of Aromatase Overexpressing and Letrozole Resistant T47D Breast Cancer Cells. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-17-05 |
0.767 |
|
2010 |
Gupta A, Peng X, Murillo G, Mehta RR, Wiehle R, Mehta RG. Abstract 5691: Significance of combination treatment of antiprogestin and aromatase inhibitors in aromatase overexpressing T47D breast cancer cells Cancer Research. 70: 5691-5691. DOI: 10.1158/1538-7445.Am10-5691 |
0.707 |
|
1999 |
Mehta R, Gupta A, Dewan S, Chellani H. Hodgkin's disease presenting with bone involvement. Indian Pediatrics. 36: 925-7. PMID 10744874 |
0.403 |
|
Show low-probability matches. |